Everest Medicines Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-606.00
-1,129.00
-933.00
-287.00
-1,215.00
-6,358.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-31.00
-185.00
-89.00
-34.00
41.00
85.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-122.00
-758.00
-858.00
-1,344.00
-879.00
-530.00
Cash Flow from Investing Activities
-751.00
1,056.00
831.00
-1,195.00
-1,176.00
-584.00
Cash Flow from Financing Activities
1,944.00
62.00
19.00
-29.00
-92.00
6,335.00
Net Cash Inflow / Outflow
1,041.00
391.00
35.00
-2,499.00
-2,218.00
4,916.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-29.00
31.00
42.00
69.00
-70.00
-304.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Everest Medicines Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-606.479567711912
3056.22323348007
-3,662.00
-119.84%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-31.0737636179447
65.5922623891756
-96.00
-147.37%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-122.426420704024
3447.67854481235
-3,569.00
-103.55%
Cash Flow from Investing Activities
-751.258015086529
-4084.5309920578
3,333.00
81.61%
Cash Flow from Financing Activities
1944.57534774319
-2919.66988187557
4,863.00
166.60%
Net Cash Inflow / Outflow
1041.05242045395
-3662.92842223468
4,703.00
128.42%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-29.8384914986916
-106.406093113667
77.00
71.96%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 83.85% vs 11.72% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-122.43
-758.09
83.85%






